ANI Pharmaceuticals downgraded to Hold from Buy at Truist
PremiumThe FlyANI Pharmaceuticals downgraded to Hold from Buy at Truist
2M ago
Alimera Stockholders Approve Merger to Become Subsidiary
Premium
Company Announcements
Alimera Stockholders Approve Merger to Become Subsidiary
2M ago
Alimera Sciences trading resumes
Premium
The Fly
Alimera Sciences trading resumes
2M ago
Processa Pharmaceuticals appoints Skibsted as CFO
PremiumThe FlyProcessa Pharmaceuticals appoints Skibsted as CFO
4M ago
Alimera Sciences downgraded to Neutral from Buy at Alliance Global Partners
Premium
The Fly
Alimera Sciences downgraded to Neutral from Buy at Alliance Global Partners
5M ago
Alimera Sciences downgraded to Hold from Buy at Maxim
Premium
The Fly
Alimera Sciences downgraded to Hold from Buy at Maxim
5M ago
ANI Pharmaceuticals to acquire Alimera Sciences for $381M upfront
PremiumThe FlyANI Pharmaceuticals to acquire Alimera Sciences for $381M upfront
5M ago
Alimera Sciences reports Q1 EPS (12c), consensus (6c)
Premium
The Fly
Alimera Sciences reports Q1 EPS (12c), consensus (6c)
6M ago
ALIM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ALIM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100